PPIST15638
Protein Information
| Protein_Chain | C[auth L]/B[auth H] |
|---|---|
| Protein_Sequence | DIQLTQSPSSLSASIGDRVTITCRASQDIANKLAWFQQAPGKAPKSLIYAASRLQSGVPSQFSGSGSGTDFTLTIESLQAGDFATYFCQQYDSFPFTFGPGTKVDVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC/EVQLVESGGGVVQPGRSLRISCAVSGFTFGSYAMHWVRQAPGKGLEWVGVMSSDGHNEYYADSVKGRFTISRDNSRNKLYLEMNNLRVDDTAVFYCARGSDYVDDSPPLHYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC |
Peptide Information
| Peptide_Chain | A |
|---|---|
| Peptide_Sequence | PSKRSFIEDLLFNK |
| Peptide_Length | 14 |
| Non-standard residues | No |
Interaction Information
| PDB_ID | 7U0A |
|---|---|
| Method | X-RAY DIFFRACTION |
| Resolution | 1.70 angstrom |
| Structure | |
| Protein-peptide residue interaction | |
| Interaction_xlsx | Download interaction table (.xlsx) |
Reference Information
| Title | ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies. |
|---|---|
| Release_Year | 2022 |
| PMID | 35857703 |
| DOI | 10.1126/science.abq2679 |